首页> 外文OA文献 >P762 Onset of inflammatory bowel disease during treatment with secukinumab: Can anti-IL-17A be a trigger for inflammatory bowel disease?

【2h】

P762 Onset of inflammatory bowel disease during treatment with secukinumab: Can anti-IL-17A be a trigger for inflammatory bowel disease?

机译：用Secukinumab治疗期间P762发作炎症肠道病：抗IL-17A可以是炎症性肠病的触发吗？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
R Rodríguez Moncada; J M Vázquez Morón; M Rojas Feria; J M Herrera Justiniano; B Maldonado Pérez; M Castro Fernández; A Núñez Ortiz; V Cabello Rubio; H Pallarés Manrique; E Gómez Delgado; A Bejarano García;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Inflammatory Bowel Disease Onset During Secukinumab Treatment: Real Concern or Just an Expression of Dysregulated Immune Response? [J] . Fries Walter, Belvedere Alessandra, Cappello Maria, Clinical drug investigation . 2019,第8期

机译：Secukinumab治疗期间炎症性肠病发作：真正关注或只是表达失调免疫反应的表达？
2. Childhood onset inflammatory bowel disease: predictors of delayed diagnosis from the CEDATA German-language pediatric inflammatory bowel disease registry. [J] . Timmer A, Behrens R, Buderus S, The Journal of pediatrics . 2011,第3期

机译：儿童发病性炎症性肠病：CEDATA德语语言的儿童炎症性肠病登记簿诊断延迟的预测因素。
3. Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centers [J] . Tursi Antonio, Mocci Giammarco, Faggiani Roberto, European journal of internal medicine . 2019,第期

机译：Vedolizumab在炎症肠道疾病门诊患者的现实生活中是有效和安全的：一种多中心，初发性炎症肠病中心的观测研究
4. Intestinal Organoids Containing PLGA Nanoparticles for the Treatment of Inflammatory Bowel Diseases [C] . Zahra Davoudi, Nathan Peroutka-Bigus, Bryan Bellaire, Society for Biomaterials annual meeting and exposition . 2018

机译：包含PLGA纳米颗粒的肠类生物素治疗炎性肠病
5. Novel Distinct Roles for Intestinal/Macrophage Cyclooxygenase 2 and Apolipoprotein Mimetic Peptides in the Development and Treatment of Inflammatory Bowel Diseases [D] . Meriwether, David. 2018

机译：肠道/巨噬细胞环氧合酶2和载脂蛋白模拟肽在炎症性肠病的发生和治疗中的新型独特作用
6. Higher Morbidity of Monogenic Inflammatory Bowel Disease Compared to the Adolescent Onset Inflammatory Bowel Disease [O] . Kwang Yeon Kim, Eun Joo Lee, Ju Whi Kim, 2018

机译：单发性炎症性肠病的发病率比青少年发病的炎症性肠病高
7. Very early onset inflammatory bowel disease in a South Asian country where inflammatory bowel disease is emerging: a distinct clinical phenotype from later onset disease [O] . Rupa Banerjee, Partha Pal, Zaheer Nabi, 2020

机译：在南亚国家的早期发病炎症肠道疾病正在出现炎症性肠病：来自后来发病疾病的明显临床表型

P762 Onset of inflammatory bowel disease during treatment with secukinumab: Can anti-IL-17A be a trigger for inflammatory bowel disease?

著录项

引文网络

相似文献

相关主题

期刊订阅